Skip to content
Medical Health Aged Care

RACGP welcomes RSV immunisation rollout

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has welcomed Western Australia becoming the first Australian jurisdiction to rollout an infant RSV immunisation.

Respiratory syncytial virus is common respiratory infection which mostly affects young children. Although symptoms are usually mild and manageable at home, some children and adults can become extremely ill and require hospital treatment. There were 127,944 RSV cases reported last year, causing symptoms that ranged from mild to life-threatening.

The monoclonal antibody Beyfortus is a one-off injection and in clinical trials has been shown to reduce the number of children hospitalised with RSV-associated infections by 83%. It has already been used widely in Europe and the United States ahead of and during their winter months.

RACGP Western Australia Chair Dr Ramya Raman welcomed the announcement.

“I welcome the Government heeding our calls and acting decisively to help protect children from the worst effects of this virus,” she said.

“RSV must be taken seriously. It is the number one cause of hospitalisation for children aged five and under in Australia, with a quarter of these children needing intensive care. So, in addition to being a horrible experience for families, the virus places a tremendous strain on our entire healthcare system, including our hospitals.

“This is the first such supply agreement anywhere in the southern hemisphere and a real boost in our efforts to combat RSV in the community. The release of infant immunisation Beyfortus ahead of the winter months will make a real difference and I encourage families to step forward and take full advantage. Helping keep sick kids out of hospital will make such a difference, particularly as we head into the colder months when respiratory conditions such as RSV can be more prevalent and the pressures on our hospital system a very real concern.”

Dr Raman reminded all families to be patient.

“My message to families is to please be patient when contacting your local practice to secure a vaccination,” she said.

“We await official confirmation; however, it appears that immunisations may be available from your usual, trusted GP in April this year. This announcement has only just been made and rolling out the program may take time. Please keep in mind too that we may not have all the doses we need right away. GPs and practice teams will do the best we can to get as many jabs in arms as quickly as possible so please be respectful in all your dealings with staff including via phone.

“We are very fortunate as a community to have access to these immunisations so let’s work together and get it done. Remember that GPs and practice teams will be doing our very best to deliver this in communities across the state.”

~ENDS

RACGP spokespeople are available for interview.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

 

Email: media@racgp.org.au (we will respond promptly to all media inquiries).

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care, Research Development
  • 06/09/2024
  • 15:19
La Trobe University

Breakthrough in the hunt for broad-spectrum malaria therapy

Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species. The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different stages of the disease. Led by Professor Michael Foley, Professor Robin Anders and PhD candidate Dimuthu Angage at the La Trobe Institute for Molecular Science (LIMS), the research also showed that WD34 can protect against several different malaria parasite species. Professor Foley said the discovery…

  • Medical Health Aged Care
  • 06/09/2024
  • 10:16
Royal Australian College of GPs

NSW Government’s expanded role for pharmacy is reckless and unsafe for patients: RACGP

The New South Wales Government’s move to expand the scope of pharmacists to treat a range of conditions is politically driven and risks the health of people across the state, says the Royal Australian College of GPs. Health Minister Ryan Park made the announcement at a Pharmacy Guild conference last night that work was underway to expand pharmacists' scope to treat ear infections, wound management, nausea, gastro-oesophageal reflux disease, acne, and muscle and joint pain. RACGP NSW Chair Dr Rebekah Hoffman slammed the move as reckless and putting politics before patient safety. “This is politically driven policy, and it has…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 06/09/2024
  • 05:00
Lloyds Auctioneers and Valuers

Bid for a Cause: Whisky Auction Supports Brain Cancer Fight

After Jack was diagnosed with Glioblastoma Multiforme (GBM), one of the most aggressive and deadly brain cancers, he was given just 12 months to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.